Working… Menu

UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma (TT4B)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT00734877
Recruitment Status : Recruiting
First Posted : August 14, 2008
Last Update Posted : October 16, 2018
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
University of Arkansas